Entitlement Offer
Filed with ASX · · 14 pages · English
In the deck
Earlier from Micro-X
- Nano Commercialisation Update - K number received from FDA
- Nano Commercialisation Update - ISO 13485 Accreditation
- Nano Commercialisation Update
- Appendix 4E and 2016 Annual Report
- Micro-X & Carestream Sign Development and Supply Agreements
Later from Micro-X
- Micro-X Entitlement Offer now fully underwritten
- Successful completion of $4.8M entitlement offer
- Carestream receives FDA 510(k) Approval for Nano
- R&D tax rebate
- Appendix 4E and 2017 Annual Report
Follow Micro-X into a list and get an email when it puts out news.
Follow Micro-X